Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2597)	9/22/2009 12:26:37 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

About CHIP, which has been doing well in the last two days.<g> Message 25962120 Bernard

To: Jibacoa who wrote (2597)	2/2/2010 2:39:56 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

BSDM was up 64.67% at its intraday H this morning and it is still up 34.72% with volume of > 1,552,100 about 50x its ADV.<g> bigcharts.marketwatch.com The stock opened with an UG. Volume is still below the 11M traded on Sep22 bigcharts.marketwatch.com BSD reported the publication of a news article on the evolving role of hyperthermia in cancer therapy. The article stated that, “Successful use of targeted heat therapy with chemotherapy in treatment of soft-tissue sarcoma has given U.S. advocates of local hyperthermia new hope that the treatment they so believe in will now be taken seriously.” The article reviewed the EORTC/NCI PIII on 341 high risk sarcoma patients, which showed a significant improvement in disease-free survival and demonstrated that patients were 30% more likely to be alive and cancer-free almost three years after starting treatment if hyperthermia was added to their chemotherapy treatment. <g> As previously mentioned, the stock has a good amount of resistance above $3 and it seems prudent to wait for t to close above the $3 level.<g> bigcharts.marketwatch.com Bernard